Abrezekimab
Based on 1 Customer Validation
Abrezekimab (UCB4144; VR 942) is a humanized, high-affinity, neutralizing anti-human-IL-13 antibody fragment that binds to IL-13. Abrezekimab prevents IL-13 binding to the IL-13 Rα1 subunit. Abrezekimab can be used for the research of asthma.
Para uso exclusivo en investigación. No vendemos a pacientes.
- Pureza : 95.00%
- No. CAS: 2043952-59-4
- Peso molecular:48.1 kDa
-
Almacenamiento:Shipping with dry ice
Please store the product under the recommended conditions in the Certificate of Analysis.
Actividad biológica
Descripciòn
Isotype
Fab-G1-kappa
Species Reactivity
Human
IC50 & Target
[1]|
IL-13 |
In Vivo
Gene ID
Accession
Conjugated
Unconjugated
Reconsititution
The product can be reconstituted/diluted with sterile PBS or saline.
Format
-
Fab-G1-kappa
Aplicación
ELISA, FACS, Functional assay
Chemical Information
-
No. CAS 2043952-59-4
-
Appearance Liquid
-
Peso molecular 48.1 kDa
-
Color Colorless to light yellow
-
SMILES
[Abrezekimab]
-
Synonyms
UCB4144; VR 942
-
Envío
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
-
Ficha de datos (256 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Inhibitory Antibodies User Guide (603 KB)
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)